Clinical trial
Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for…
NCT00316108 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00316108 |
|---|---|
| Title | Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH) |
| Official title | Boston Scientific EPI: A Carotid Stenting Trial for High-Risk Surgical Patients |
| Acronym | BEACH |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Carotid Artery Diseases, Stroke, Cerebral Arteriosclerosis |
| Intervention type | Device |
| Interventions | WALLSTENT® Endoprosthesis™ |
| Enrollment | 747 |
| Start date | Feb 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Apr 20, 2006 |
| Last update posted | Aug 28, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: